The cell line development service global market is expected to reach $1,702.2 million by 2028 growing at a double digit CAGR from 2020 to 2028. Increasing demand for monoclonal antibodies ...

Curia signs license agreement with MilliporeSigma to support production of proteins and antibodiesALBANY, N.Y., June 20, 2023 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development ...

The demand for cell line development services is anticipated to grow at an average year-on-year growth rate of 7.4% during the years from 2023 to 2033. The new market analysis report by FMI estimates ...

The cell line development market is growing at a CAGR of approximately 8-10% due to the increasing adoption of cell-based therapies. Key drivers include the rising demand for monoclonal antibodies, ...

AMERSHAM, England, Oct. 6, 2022 /CNW/ -- Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cell line development and viral vector ...

Generating stable cell lines that maintain consistent gene expression through thaw, passage and experiments remains a significant challenge. This complexity increases when multiple transgenes are ...

Cell line development is key for biopharmaceutical production, cancer research, drug screening and functional gene studies. In this webinar, you’ll learn how researchers from Stanford University and ...

Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues ...

Detailed price information for Living Cell Technologies Ltd (LVCLF) from The Globe and Mail including charting and trades.

Discover how to streamline your cell line development process for recombinant protein and monoclonal antibody production with this in-depth eBook. Whether you're working with CHO, HEK293, or ...

Insourcing cell-line development has helped a fast-growing antibody manufacturer to deliver process improvements and strengthen communication with their contract manufacturer, according to Genmab ...

ALBANY, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced it has signed a licensing agreement with MilliporeSigma, ...